Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - April 2014


Modern Approaches to Identifying, Understanding and Controlling Variables and Transfer of Knowledge

14 Apr 2014 - 14 Apr 2014 - BioCity Edinburgh, UK



Bookmark and Share


Validated processes can often fail during the transfer stage and result in non-value added investment of resources to troubleshoot the problems. Two main reasons for this are; either the variables which contribute to inconsistencies of the outcome of the procedure have not been identified or controlled adequately or the transfer of knowledge of the process has not been performed effectively.   Whatever the process may be identifying, understanding and controlling variables is a key strategy towards enabling the process to perform to give a consistent outcome during routine use. In the event the process has to be transferred to a new environment, effective knowledge transfer of the process is vital to success.   There are many courses available today which cover the quality by design approach to developing manufacturing processes and analytical procedures so why should you attend this workshop? A process is a process and this one day practical workshop provides the opportunity to learn and apply the basic skills required to investigate, identify and understand variables, to develop a consistent process and transfer the knowledge of that process successfully. Participants will have the opportunity to use quality by design tools and concepts such as the target profile, risk assessment and control strategy to develop a simple process through experimentation and data analysis and then communicate it effectively to others. The skill set and mindset experienced during the classroom team exercises will provide a solid foundation when dealing with industry processes This workshop was designed to provide hands on experience using QbD tools and concepts such as the target profile, risk assessment and control strategy by applying them in the design and development of a simple process. This is achieved through experimentation with a statapult and/or making “Tasty Tablets”. The actual classroom process(s) will depend on the number and the background of attendees.

Further information
Scientific News
New Cancer Drug Target in Dual-Function Protein
Scientists at The Scripps Research Institute (TSRI) have identified a protein that launches cancer growth and appears to contribute to higher mortality in breast cancer patients.
Penn State, TB Alliance, and GSK Partner To Discover New Treatments For TB
A new collaboration between TB Alliance, GSK, and scientists in the Eberly College of Science seeks to find new small molecules that can be used to create antibiotics in the fight against tuberculosis (TB).
Molecular Map Provides Clues To Zinc-Related Diseases
Mapping the molecular structure where medicine goes to work is a crucial step toward drug discovery against deadly diseases.
Platelets are the Pathfinders for Leukocyte Extravasation During Inflammation
Findings from the study could help in the prevention and treatment of inflammatory pathologies.
Genetic Research Can Significantly Improve Drug Development
With drug development costs topping $1.2bn (£850 million) to get a single treatment to the point it can be sold and used in the clinic, could genetic analysis save hundreds of millions of dollars?
New Method Opens Door to Development of Many New Medicines
Findings from TSRI reveal human proteins are better drug targets than previously thought.
Diagnosing Systemic Infections Quickly, Reliably
Team develop rapid and specific diagnostic assay that could help physicians decide within an hour whether a patient has a systemic infection and should be hospitalized for aggressive intervention therapy.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Blood Test That Detects Early Alzheimer’s Disease
A research team, led by Dr. Robert Nagele from Rowan University School of Osteopathic Medicine and Durin Technologies, Inc., has announced the development of a blood test that leverages the body’s immune response system to detect an early stage of Alzheimer’s disease – referred to as the mild cognitive impairment (MCI) stage – with unparalleled accuracy.
A New Approach to Chemical Synthesis
Communesins, originally found in fungus, could hold potential as cancer drugs.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!